Drug
Garlic oil
Garlic oil is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
completed250%
not_yet_recruiting125%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Garlic Oil As Root Filling Material in Primary Molars
NCT06755502
terminatednot_applicable
Dietary Histone Deacetylase Inhibitors (HDAC)
NCT01543074
completedphase_2
Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis
NCT01748669
completed
Effects of Garlic Supplements on Drug Metabolism
NCT00122889
Clinical Trials (4)
Showing 4 of 4 trials
NCT06755502Not Applicable
Garlic Oil As Root Filling Material in Primary Molars
NCT01543074Not Applicable
Dietary Histone Deacetylase Inhibitors (HDAC)
NCT01748669Phase 2
Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis
NCT00122889
Effects of Garlic Supplements on Drug Metabolism
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4